Debiased Conditional Independence Tests for Causal Effects
summary
The gist
The paper proposes robust tests for causal effects on potentially high-dimensional outcomes where selection into treatment may occur…
In short
The paper introduces three robust tests—AIPW, DR, and DR$∗—to measure conditional independence between outcomes and treatment assignment in high-dimensional settings. These tests determine if treatment can be predicted from outcomes better than covariates alone. They offer superior power over conventional methods while maintaining desirable statistical properties like double robustness.
Key concepts
- Conditional Independence Null Hypothesis
- This hypothesis assumes that the distribution of potential outcomes under treated and control states is identical when conditioned on covariates. In simpler terms, it tests whether treatment assignment can be predicted from the outcomes more accurately than just using the covariates X.
- Augmented Inverse Propensity Weighting (AIPW)
- This statistic is used when propensity scores are known. It measures the predictability of treatment based on outcomes, adjusting for covariates and treating both as predictors. It is efficient and provides strong statistical guarantees under certain assumptions.
- Double Residualization (DR) / DR∗
- These approaches involve partial out-covariate effects from both the treatment and outcome predictions. They test if the correlation between these residuals is zero, which signifies conditional independence. They are useful for observational data where propensity scores need to be estimated.
- Double Robustness
- This desirable statistical property means that a test remains valid even if there is misspecification in one of the models used (e.g., the outcome model). It ensures that if either the treatment or outcome model is correct, the test still provides a consistent estimate of the causal effect.
Terminology used across episodes
This episode discusses
- Debiased Conditional Independence Tests for Causal Effects · Paper Radio
- An Introduction to Double/Debiased Machine Learning
- Machine-Learning Tests for Effects on Multiple Outcomes
- Dimension Reduction for Conditional Density Estimation with Applications to High-Dimensional Causal Inference
- Cross-Fitting and Fast Remainder Rates for Semiparametric Estimation
- Kernel-based Conditional Independence Test and Application in Causal Discovery
- Inverse regression for causal inference with multiple outcomes
- Doubly Robust Conditional Independence Testing with Generative Neural Networks
The paper
Debiased Conditional Independence Tests for Causal Effects · Read on arXiv
Stanford University · University of Glasgow
Transcript
Introduction to the show: ident: Economics. The day in economics: theory, mechanisms and the evidence beneath them.
Ruth: I'm Ruth.
Warren: And I'm Warren, here with Iris.
Ruth: We're looking at the paper: "Debiased Conditional Independence Tests for Causal Effects".
Warren: Here's the gist of the paper. The paper proposes robust tests for causal effects on potentially high-dimensional outcomes where selection into treatment may occur, specifically designed to measure conditional independence between outcomes and treatment assignment by determining whether treatment can be predicted from outcomes more accurately than from covariates alone.
Ruth: The core null hypothesis is that the distributions of potential outcomes are equal under treated and control states: H 0: Y i(1) d= Y i(0) X i (1) almost surely, which is equivalent to testing conditional independence: H 0: D i Y i X 2 almost surely, or no predictability: H 0: P(D i = 1Y i, X) = P(D i = 1X) almost surely.
Warren: Three primary procedures are introduced to test this conditional independence: 1.
Ruth: A conditional randomization test based on an inverse propensity weighted mean squared error (IPW) test statistic, assuming propensity scores are known.
Paper summary: Ruth: So we're looking at this paper now called Debiased Conditional Independence Tests for Causal Effects. It addresses those tricky situations where you have high-dimensional outcomes and selection into treatment is possible.
Warren: Exactly. The core idea here is to measure if the treatment assignment can be predicted from the outcomes more accurately than just using the covariates alone. That's what they’re testing for conditional independence between outcomes and treatment assignment.
Iris: So, to put that in simpler terms, the null hypothesis they are testing is that the distributions of potential outcomes are equal under treated and control states given those covariates. That means if you know the outcomes and the covariates, you can't predict whether someone got treated better than someone who didn't get treated based on those outcomes.
Ruth: Right. They frame it as testing conditional independence, specifically checking if treatment assignment is independent of the outcomes when conditioned on the covariates. It’s basically asking if getting a specific outcome tells you something new about whether you were assigned that treatment or not beyond what the covariates already tell us.
Warren: And they propose three main procedures to test this conditional independence. First, there's a conditional randomization test based on an inverse propensity weighted mean squared error test statistic, but that assumes we already know the propensity scores.
Iris: That first one is interesting because it controls the size in finite samples if you actually know those propensity scores. Then they have a double-residualization approach, which involves partially removing the covariate effects from both the treatment predictions and the outcome predictions and checking if those remaining residuals are uncorrelated.
Ruth: And that second approach is built around testing whether the correlation between those residuals is zero. That's a way to see if there's any left over information that isn't captured by just looking at the covariates.
Warren: Finally, they have this third test based on an augmented inverse propensity weighted estimator, which uses doubly robust, Neyman-orthogonal population moments that are necessary and sufficient for that conditional independence.
Iris: That third one is built around these moments being necessary and sufficient for conditional independence. It’s a technical way to check the required structure of the distributions under the null hypothesis.
Ruth: The paper claims these procedures are designed to test for the joint distributional causal effect of treatment on outcomes under unconfoundedness, which means we're assuming no selection into treatment based on those potential outcomes is happening.
Paper summary: Warren: They claim these methods inherit nice properties like Neyman orthogonality and double robustness when the null hypothesis holds true. That’s important because it means they should behave well in large samples and even if our models are slightly wrong.
Iris: And a big practical advantage they point to is computational efficiency, which allows for generic machine learning applications and only requires estimating a small number of nuisance functions even in high-dimensional settings.
Ruth: When propensity scores have to be estimated from observational data, they construct three specific statistics: Augmented inverse propensity weighting, double residualization DR, and double residualization with augmentation DR star.
Warren: These three statistics are based on efficient, Neyman-orthogonal, doubly robust scores that measure the predictability of treatment from outcomes conditional on covariates. They test for this conditional independence between outcomes and treatment assignment.
Iris: The paper shows these tests achieve asymptotic normality under assumption four, and corollary one confirms they reach the desired asymptotic size alpha when we are testing the null hypothesis.
Ruth: The results show that AIPW, DR, and DR star tests are systematically more powerful than the conventional joint Wald test when we're in low-signal regimes. They also outperform the joint Wald test when there's covariate-driven heterogeneity or a nonzero mean effect present.
Warren: But they are consistent for the true conditional treatment effect even if our outcome model is misspecified. The AIPW, however, needs those propensity scores to be known beforehand.
Iris: That’s a key distinction: AIPW requires you to know the propensity scores, while DR and DR star can handle observational settings where you have to estimate those scores.
Ruth: The paper details how these statistics converge under assumption four. Part one shows that the estimators for AIPW, DR star, and DR all converge in probability to their respective null values under assumption four.
Warren: Part two establishes the consistency of the variance estimators, showing they converge to the asymptotic variances derived from theorem five, which depend on terms involving nuisance function errors that vanish under assumption four.
Iris: And part three proves central limit theorems for these test statistics. For AIPW and DR star, we get a distribution that converges to a normal distribution with mean zero and a specific variance term as n goes to infinity.
Paper summary: Ruth: Crucially, under the null hypothesis, the estimated value of these estimators goes to zero almost surely for all three tests. This means the test statistics converge in distribution to a standard normal distribution with mean zero and variance one.
Warren: That’s powerful because it confirms that all three proposed tests have asymptotically correct sizes when nothing is happening. They also confirm the asymptotic size alpha under the null hypothesis in part four of their analysis.
Iris: Under the alternative, if our true outcome model is well-specified, consistency means power converges to one when both parameters related to the treatment effect and outcomes are positive. If we misspecify the model, consistency still holds as long as those parameters stay positive.
Ruth: Comparing this to other tests, AIPW, DR, and DR star are systematically more powerful than the conventional joint Wald test in low-signal regimes. They also outperform the Wald test when there's covariate-driven heterogeneity or a nonzero mean effect present.
Warren: The paper benchmarks show that AIPW, DR, and DR star tests can achieve consistently high power across different outcome distributions, reaching near one hundred percent even with as few as five hundred observations. The Wald test stays below twenty percent in complex designs like Mixtures and Heavy Tails.
Iris: But the small sample performance shows that while DR/DR star and AIPW dominate when the treatment effect averages to zero, other tests like KCI, GCM, and the joint Wald test dominate when that average treatment effect is not zero.
Ruth: So, wrapping up this paper titled Debiased Conditional Independence Tests for Causal Effects. The authors are Susan Athey, Maria Nareklishvili, and Jann Spiess. They propose these three tests to robustly measure conditional independence between outcomes and treatment assignment in high-dimensional settings with selection into treatment possible.
Warren: Essentially, they are providing tools to see if the treatment can actually be predicted from the outcomes better than just looking at the covariates alone. The implication is that we have a more reliable way to assess the joint distributional causal effect of an intervention under unconfoundedness.
Iris: The paper suggests these methods are very useful because they offer good properties like double robustness and Neyman orthogonality when they hold true, which means they should work reliably even if our functional forms are a bit off.
Ruth: And the practical side is that for observational data where propensity scores need estimation, the DR and DR star tests provide a way to do it consistently. It’s about making causal inference more accessible when the data is messy.
Conclusion: Ruth: So we're wrapping up on "Debiased Conditional Independence Tests for Causal Effects." This paper is about building these three tests to check if treatment assignment is actually predictable from the outcomes, beyond just using the covariates.
Warren: Right, so they're not just looking at correlation; they're trying to isolate that specific causal effect by measuring conditional independence between those two things. It’s about seeing if you can predict getting treated better based on what happens to your outcome.
Iris: What I find important is how they handle the messy part—when you don't know the propensity scores, which is almost always the case in real observational data. They give us these three specific tools, AIPW, DR, and DR star, which are designed to work even when we have to estimate those scores.
Ruth: And what this means for us is that we’ve got a much more robust way of assessing the joint causal effect when selection into treatment might be happening in high-dimensional settings. It gives us more confidence than just running the standard regression tests.
Warren: The real power here is that these methods keep good properties like double robustness even when our models are slightly wrong about the outcome structure. That’s huge for practical applications, because we don't always have perfect data or perfect models.
Iris: And they show that under certain conditions, like when the true treatment effect is positive and the outcome model is pretty good, these tests can actually get really powerful with as few as five hundred observations. That’s a big deal for getting reliable estimates in smaller studies.
Ruth: Exactly, so it shifts our approach from just testing if a relationship exists to testing if that relationship has causal meaning under those complex conditions. But we still have to be careful about what these tests can and cannot do, and where they might stop working.
More episodes
- Daily Summary for 2026-11-19
- 2608.21274-Recommendation Quality and the Concentration of Consumption: Experimental Evidence from Netflix
- 2408.02757-A nonparametric test for diurnal variation in spot correlation processes
- 2306.16393-High-Dimensional Canonical Correlation Analysis
- 2605.17299-Geometric Brownian motion with intermittent entries and exits
- 2607.04753-Fooling Yourself: how narratives shape beliefs
- 2408.14671-Inference on Treatment Effects with Repeatedly Mismeasured High-Dimensional Controls
- 2201.06898-Difference-in-Differences Estimators for Treatments Continuously Distributed at Every Period
- 2501.15307-Influence Functions: A Unified Differentiation-Based Framework
- The day in conversation for 2026-11-19